Navigation Links
Guava Technologies Celebrates Tenth Anniversary
Date:2/6/2008

A decade of helping scientists and clinicians understand life one cell at a

time

HAYWARD, Calif., Feb. 6 /PRNewswire/ -- This year marks 10 years of Guava Technologies bringing sophisticated, yet uniquely easy-to-use, cellular analysis technologies directly to the lab benches of thousands of scientists and clinicians worldwide. Since 1998, the company has experienced continued success, achieving several significant milestones, including introduction of the first commercial microcapillary flow cytometer and introduction of a low-cost automated cell counting system for monitoring treatment of HIV/AIDS in remote parts of the world.

Guava Technologies develops microcapillary flow cytometers, which accommodate smaller sample volumes, generate less waste, have lower operating costs, and are easier to set up and maintain than the typical traditional flow cytometer. By leveraging the unique attributes of microcapillary based flow cytometry, the company's integrated systems enable scientists and clinicians not specialized in the technology to perform complex cellular analyses directly from their own lab bench -- quickly, simply, and cost-effectively. The company now has five systems and an ever-growing portfolio of reagents and assays on the market.

"We are exceptionally proud that virtually any scientist or clinician can learn to use a Guava System in less than one day," said Lawrence Bruder, Chief Executive Officer. "We have made steady progress toward our goal of making flow cytometry -- an absolutely critical technology for cell analysis -- directly accessible to almost any scientist or clinician who could benefit from it."

In addition, Guava Technologies has established a strong global sales and service organization with offices in Hayward, California, US, and Stamford, UK. "Truly believing that our customers come first, we have worked hard to ensure that we stand behind our products, and that our R&D efforts address our customers' needs," continued Mr. Bruder. The company's user base now exceeds 1,300 users worldwide and continues to grow steadily.

"Our ten-year celebration provides an opportunity for us to reflect on where we've come from and establish new goals and initiatives that will continue to drive growth through the next decade and beyond," said Mr. Bruder. "In 2007, we were recognized by Inc. Magazine as one of the fastest growing private companies in the US, and 2008 is certainly shaping up to be an equally, if not an even more, exciting year."

Guava Technologies, Inc. (http://www.guavatechnologies.com) is a private biotechnology and medical device company that designs and manufactures easy-to-use, on-demand, benchtop cell analysis systems. In 2007, Guava Technologies achieved ISO13485 certification for the design and manufacture of medical devices. All Guava Systems are friendly, delivering turnkey assays that include optimized reagents and assay-specific software for applications such as cell counting/viability, antibody quantification, cell cycle, cytotoxicity, apoptosis, and more. Minimizing time from hypothesis to conclusion, Guava Systems are ideal for a broad range of medical and biomedical applications, and are helping scientists around the world understand life one cell at a time.

The Guava EasyCD4(R) System for monitoring treatment of HIV/AIDS is not available for sale in the US, EU, Japan, and some other countries; contact a Guava Technologies representative for availability in your region.

Guava, Guava Technologies Logo, and all other trademarks are property of Guava Technologies, Inc.


'/>"/>
SOURCE Guava Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... LAVAL, QC , April 20, 2017 /PRNewswire/ - Prometic Life ... today presented new results at the International Liver Congress ("ILC") ... Liver ("EASL") in Amsterdam on the ... in a mouse model of obesity and metabolic syndrome. ... According to Dr. Lyne Gagnon, ...
(Date:4/20/2017)... MN and Bethesda, MD (PRWEB) , ... April ... ... Advancing Innovation announce the formation of a unique intellectual property (IP) sharing and ... potential of their most promising inventions. A main component of this effort is ...
(Date:4/20/2017)... 2017 For today, Stock-Callers.com redirects investors, ... development and clinical research aimed at treating diseases and medical ... Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), ... can access our complimentary research reports on these stocks now ... http://stock-callers.com/registration ...
(Date:4/19/2017)... ... 2017 , ... Alisa Wright, founder and CEO of Singota Solutions , ... Pharmacy in Lafayette, Indiana. , The Distinguished Alumni Award was established in 1984 ... other scientific endeavors. , Wright began her career in the pharmaceutical industry with ...
Breaking Biology Technology:
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):